A novel missense mutation in ADRB3 increases risk for type 2 diabetes in a Mexican American family

Diabetes/Metabolism Research and Reviews

Volumn 22, Issue 4, 2006, Pages 331-336

  Lehman, Donna M ^a   Hamlington, Jeanette ^a   Hunt, Kelly J ^a   Leach, Robin J ^b   Arya, Rector ^a   Abboud, Hanna ^a   Duggirala, Ravindranath ^c   Blangero, John ^c   Göring, Harald H H ^c   Stern, Michael P ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b University of Texas Health Science Center   (United States)

^c SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

ADRB3 gene; Hispanic; Trp64Arg polymorphism; Type 2 diabetes mellitus

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; GLUCOSE; ISOLEUCINE; METHIONINE;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CONTROLLED STUDY; FAMILY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; HISPANIC; HUMAN; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; ONSET AGE; PATHOGENESIS; PEDIGREE ANALYSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE ANALYSIS; STATISTICAL SIGNIFICANCE;

3' UNTRANSLATED REGIONS; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; DIABETES MELLITUS, TYPE 2; DNA PRIMERS; FEMALE; HUMANS; MALE; MEXICAN AMERICANS; MUTATION, MISSENSE; PEDIGREE; RECEPTORS, ADRENERGIC, BETA-3; TEXAS; VARIATION (GENETICS);

EID: 33746060153     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.620     Document Type: Article

References (26)

1. Perfetti R, Hui H, Chamie K, et al. Pancreatic beta-cells expressing the Arg64 variant of the beta(3)-adrenergic receptor exhibit abnormal insulin secretory activity. J Mol Endocrinol 2001; 27(2): 133-144.
2. Chamberlain PD, Jennings KH, Paul F, et al. The tissue distribution of the human beta3-adrenoceptor studied using a monoclonal antibody: direct evidence of the beta3-adrenoceptor in human adipose tissue, atrium and skeletal muscle. Int J Obes Relat Metab Disord 1999; 23(10): 1057-1065.
3. Emorine LJ, Marullo S, Briend-Sutren MM, et al. Molecular characterization of the human beta 3-adrenergic receptor. Science 1989; 245(4922): 1118-1121.
4. Mizuno K, Sawa M, Harada H, et al. Discovery of 1,7-cyclized indoles as a new class of potent and highly selective human beta3-adrenergic receptor agonists with high cell permeability. Bioorg Med Chem 2005; 13(3): 855-868.
5. Walston J, Silver K, Bogardus C, et al. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med 1995; 333(6): 343-347.
6. Christiansen C, Poulsen P, Beck-Nielsen H. The Trp64Arg mutation of the adrenergic beta-3 receptor gene impairs insulin secretion: a twin study. Diabet Med 1999; 16(10): 835-840.
7. Leineweber K, Buscher R, Bruck H, Brodde OE. Beta-adrenoceptor polymorphisms. Naunyn Schmiedebergs Arch Pharmacol 2004; 369(1): 1-22.
8. Garcia-Rubi E, Calles-Escandon J. Insulin resistance and type 2 diabetes mellitus: its relationship with the beta 3-adrenergic receptor. Arch Med Res 1999; 30(6): 459-464.
9. Arner P, Hoffstedt J. Adrenoceptor genes in human obesity. J Intern Med 1999; 245(6): 667-672.
10. Marti A, Corbalan MS, Martinez-Gonzalez MA, Martinez JA. TRP64ARG polymorphism of the beta 3-adrenergic receptor gene and obesity risk: effect modification by a sedentary lifestyle. Diabetes Obes Metab 2002; 4(6): 428-430.
11. Corbalan MS, Marti A, Forga L, Martinez-Gonzalez MA, Martinez JA. The risk of obesity and the Trp64Arg polymorphism of the beta(3)-adrenergic receptor: effect modification by age. Ann Nutr Metab 2002; 46(3-4): 152-158.
12. Ochoa MC, Marti A, Azcona C, et al. Gene-gene interaction between PPAR gamma 2 and ADR beta 3 increases obesity risk in children and adolescents. Int J Obes Relat Metab Disord 2004; 28(Suppl 3): S37-S41.
13. Koda M, Ando F, Niino N, Shimokata H, Miyasaka K, Funakoshi A. Association of cholecystokinin 1 receptor and beta3-adrenergic receptor polymorphisms with midlife weight gain. Obes Res 2004; 12(8): 1212-1216.
14. Phares DA, Halverstadt AA, Shuldiner AR, et al. Association between body fat response to exercise training and multilocus ADR genotypes. Obes Res 2004; 12(5): 807-815.
15. Stern MP, Duggirala R, Mitchell BD, et al. Evidence for linkage of regions on chromosomes 6 and 11 to plasma glucose concentrations in Mexican Americans. Genome Res 1996; 6(8): 724-734.
16. Hunt KJ, Lehman DM, Arya R, et al. Genome-wide linkage analyses of type 2 diabetes in Mexican Americans: the San Antonio family Diabetes/ Gallbladder Study. Diabetes 2005; 54(9): 2655-2662.
17. American Diabetes Association: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20(7): 1183-1197.
18. American Diabetes Association: Summary of revisions for the 2002 clinical practice recommendations. Diabetes Care 2002; 25: S1-S148.
19. Yoo B, Pankratz VS, de Andrade M. Practical application of residuals from survival models in quantitative trait linkage analysis. Genet Epidemiol 2001; 21(Suppl 1): S811-S816.
20. Boerwinkle E Chakraborty R, Sing CF. The use of measured genotype information in the analysis of quantitative phenotypes in man. I. Models and analytical methods. Ann Hum Genet 1986; 50: (Pt 2): 181-194.
21. Almasy L, Blangeroc, J. Exploring positional candidate genes: linkage conditional on measured genotype. Behav Genet 2004; 34(2): 173-177.
22. Ohmura T, Ueda T, Hashimoto Y, Imoto T. Tolerance of point substitution of methionine for isoleucine in hen egg white lysozyme. Protein Eng 2001; 14(6): 421-425.
23. Neel JV. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet 1962; 14: 353-362.
24. Atef N, Lafontan M, Double A, Helary C, Ktorza A, Penicaud L. A specific beta 3-adrenoceptor agonist induces increased pancreatic islet blood flow and insulin secretion in rats. Eur J Pharmacol 1996; 298(3): 287-292.
25. Cawthorne MA, Carroll MJ, Levy AL, et al. Effects of novel beta-adrenoceptor agonists on carbohydrate metabolism: relevance for the treatment of non-insulin-dependent diabetes. Int J Obes 1984; 8(Suppl 1): 93-102.
26. Yoshida T, Sakane N, Umekawa T, Sakai M, Takahashi T, Kondo M. Mutation of beta 3-adrenergic-receptor gene and response to treatment of obesity. Lancet 1995; 346(8987): 1433-1434.